Cel-Sci Corporation (CVM)
NYSE: CVM · Biological Products, (No Diagnostic Substances) · Vienna, VA · filing with the SEC since 1996
Filings
393 filings since 2017 beside 293 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company
10-K
Annual report for the fiscal year ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Dec 29, 2026
10-Q
Quarterly report for the quarter ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Feb 14, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Jul 2, 2026.
Filings a yearinsider forms included
6595544747516048
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 2 times in the last 36 months, the newest Nov 15, 2024.SEC letters: 18 in the last 36 months, the newest May 7, 2026.A late-filing notice, Form NT 10-K, filed Dec 30, 2024.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Jun 16, 2026
8-K items 1.01, 8.01, 9.01
Major agreement signed; Other event · Current report
Jun 14, 2026
May 13, 2026
8-K items 1.01, 8.01, 9.01
Major agreement signed; Other event · Current report
May 11, 2026
Aug 29, 2025
8-K items 1.01, 8.01, 9.01
Major agreement signed; Other event · Current report
Aug 27, 2025
40 of 393 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.